This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Optimizing computed tomography simulation wait times in a busy radiation medicine program.
Practical radiation oncology · 2017
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer.
Oncotarget · 2015
Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells.
Radiation research · 2014
19 publications.
Optimizing computed tomography simulation wait times in a busy radiation medicine program.
Roussos J, Zahedi P, Spence T, Swanson LA, Li-Cheung F, Cops F, Darcy P, Chhin V, Moyo E, Warde P, Foxcroft S, Liu FF
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer.
Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW, Liu FF
Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells.
Cui L, Tse K, Zahedi P, Harding SM, Zafarana G, Jaffray DA, Bristow RG, Allen C
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase.
Yip KW, Zhang Z, Sakemura-Nakatsugawa N, Huang JW, Vu NM, Chiang YK, Lin CL, Kwan JY, Yue S, Jitkova Y, To T, Zahedi P, Pai EF, Schimmer AD, Lovell JF, Sessler JL, Liu FF
Multi-arm PEG/silica hydrogel for sustained ocular drug delivery.
Lu C, Zahedi P, Forman A, Allen C
Thermosensitive depot-forming injectable phosphatidylcholine blends tailored for localized drug delivery.
Grant J, Zahedi P, Tsallas A, Allen C
Neoplastic cell response to tiopronin-coated gold nanoparticles.
Cui L, Zahedi P, Saraceno J, Bristow R, Jaffray D, Allen C
Recent advances in drug delivery strategies for treatment of ovarian cancer.
Zahedi P, Yoganathan R, Piquette-Miller M, Allen C
An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels.
Zahedi P, Stewart J, De Souza R, Piquette-Miller M, Allen C
Chemotherapy dosing schedule influences drug resistance development in ovarian cancer.
De Souza R, Zahedi P, Badame RM, Allen C, Piquette-Miller M
Science to Business (2014)
Principal investigators: Zahedi, Payam
Keywords: Cancer Of The Reproductive System; Development Of Drug Delivery Systems; Drug Formulation; Pharmaceutics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medical Biophysics
- Radiation Oncology
- Pharmaceutical Sciences
- School of Engineering Technology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Christine Allen
Medical Biophysics
11 shared papers, latest 2014
Micheline Piquette-Miller
Faculty
9 shared papers, latest 2012
Fei-Fei Liu
Radiation Oncology
3 shared papers, latest 2017
Rashid Abu-Ghazalah
School of Engineering Technology
1 shared papers, latest 2006
David Jaffray
Pharmaceutical Sciences
1 shared papers, latest 2013
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.